Top CDMOs in APAC
Pharma Tech Outlook
Home »CDMO » Top CDMOs in APAC
The Future of Vaccines: Advances In Manufacturing Technology, Preventable Diseases, R&D, And Public Health Management
line

Top 10 CDMOs in APAC - 2023

line

The Asia-Pacific (APAC) region has emerged as a powerhouse in the pharmaceutical and biotechnology industries, and Contract Development and Manufacturing Organizations (CDMOs) play a pivotal role in this dynamic landscape.

The APAC region is witnessing an unprecedented surge in technological advancements across various industries, and the pharmaceutical sector is no exception. CDMOs are embracing cutting-edge technologies, such as artificial intelligence, machine learning, and advanced analytics, to enhance efficiency in drug development and manufacturing processes. These innovations not only accelerate timelines but also improve product quality, ensuring that APAC remains a global hub for pharmaceutical manufacturing.

The demand for biopharmaceuticals continues to grow globally, and APAC is at the forefront of this paradigm shift. CDMOs in the region are investing heavily in bioprocessing capabilities to cater to the increasing demand for biologics and biosimilars. This includes expanding infrastructure, adopting single-use technologies, and developing expertise in cell and gene therapies. As the biopharmaceutical market matures, APAC is poised to become a key player in this domain.

APAC countries are actively working to harmonize and streamline their regulatory frameworks to attract more pharmaceutical and biotech investments. CDMOs operating in the region are aligning with international quality standards and regulatory requirements, fostering a conducive environment for global collaborations. This commitment to regulatory excellence enhances the credibility of APAC-based CDMOs, making them preferred partners for multinational pharmaceutical companies.

As APAC continues to establish itself as a key player in the global pharmaceutical industry, CDMOs in the region are poised to play a pivotal role in shaping the future of drug development and manufacturing. Stakeholders in the pharmaceutical and biotech sectors should closely monitor these trends to capitalize on the opportunities emerging in this vibrant and dynamic market.

    Top CDMOs in APAC

    Elixirgen Scientific Japan
    Read full profile →
    Elixirgen Scientific is a global leader in induced pluripotent stem cell (iPSC) differentiation technology and mRNA manufacturing, with a mission to advance science and medicine with fast, functional, and scalable iPSC differentiation products and services and high quality mRNA services. ... read full profile
    Alban Pharma Llc
    Alban Pharma LLC (ALBAN) is a leading CDMO/CMO management agency specializing in contract manufacturing, offering comprehensive services to international pharmaceutical companies, from formulation development to commercial manufacturing. Their Injectable Contract manufacturing site is MHRA GMP and FDA approved, producing a wide range of injectable drugs for global supply. With aseptic filling lines and lyophilizers, ALBAN ensures high-quality production and timely delivery.
    AstaTech
    AstaTech is a pioneering chemistry CRO company, with over 100 chemists, 40% of whom hold Ph.D. or MS degrees. AstaTech delivers premium chemicals, offering over 100,000 advanced intermediates and drug-like building blocks. Their expertise spans from drug discovery to manufacturing, providing high-quality solutions to over 10,000 customers worldwide.
    Bora Pharmaceuticals
    Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO) specializing in complex oral solid dose, liquids, semi-solids, ophthalmics, and nasal sprays for pharmaceutical Rx and OTC products. Operating from early phase clinical to commercial manufacturing, Bora provides tailored services to biologics developers. Their extensive services encompass pharmaceutical development, manufacturing, and innovative solutions for the pharmaceutical industry.
    FORECYTEBIO
    FORECYTEBIO is a pioneering CDMO company specializing in cutting-edge Cell and Gene Therapy (CGT) solutions. They provide a comprehensive suite of services, spanning from process development to GMP production, for a wide range of CGT products, including plasmids and viral vectors like AAV, Adeno Virus, Lenti Virus, Oncolytic Virus, as well as cell processing for CAR-T, TCR-T, and CAR-NK therapies.
    Langhua Pharmaceutical
    Langhua Pharmaceutical, a prominent pharmaceutical enterprise under Viva Biotech Holding Group, excels in integrating R&D, production, and trade. Langhua offers a seamless CDMO solution for the entire drug life cycle, emphasizing quinolones, spironolactone, olanzapine, and antiviral APIs. As a global leader, their mission is to enhance medicine availability and affordability, making significant contributions to human health.
    Medistronics
    Medistronics is a leading regulatory consulting service provider specializing in medical devices and in vitro diagnostic reagents. Medixtron excels in registration, clinical trials, quality management, and production management. Their innovative approach and deep industry insights have facilitated the successful issuance of over 1,500 registration certificates for both imported and domestic medical devices.
    PharmaBio Corporation
    PharmaBio Corporation, Japan’s pioneering regenerative medicine development and manufacturing contract company, is at the forefront of innovation. Specializing in regenerative medicine product development, contract manufacturing, and various testing services, they lead the industry with cutting-edge solutions. Their commitment to advancing healthcare is evident through the design and construction of state-of-the-art cell preparation facilities, ensuring safe and effective treatments for all.
    SFI Health
    SFI Health, a global natural healthcare leader, pioneers cutting-edge solutions in microbiome and cognitive health. Their passion drives the development and delivery of world-class natural health products, empowering informed health choices. SFI Health is dedicated to enhancing human quality of life. Their commitment to promoting diversity and continuous innovation cements their position as trusted providers of proven natural health solutions.
    TOT BIOPHARM
    TOT BIOPHARM, a leading biopharmaceutical partner, excels in providing top-tier CDMO solutions for global clients. With advanced technical platforms and robust quality systems, they specialize in accelerating biologics development, particularly antibody-drug conjugates (ADCs). Their integrated platform ensures streamlined production, reducing costs and regulatory risks. TOT BIOPHARM boasts a large-scale commercial GMP production base, offering end-to-end services from R&D to successful commercialization.